Douglas A Treco Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Douglas A Treco is of CRISPR Therapeutics AG. Currently has a direct ownership of 22,000 shares of CRSP, which is worth approximately $1.21 Million. The most recent transaction as insider was on Aug 06, 2025, when has been sold 20,000 shares (Common Shares) at a price of $57.03 per share, resulting in proceeds of $1,140,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22K
n/a 3M change
n/a 12M change
Total Value Held $1.21 Million

Douglas A Treco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 06 2025
BUY
Open market or private purchase
$1,140,600 $57.03 p/Share
20,000 Added 47.62%
22,000 Common Shares

Also insider at

INZY
Inozyme Pharma, Inc. Healthcare
CEO & Chairman
DAT

Douglas A Treco

Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP